In reply [8]

JAMA

Volumn 295, Issue 23, 2006, Pages 2723-2724

  Harris, Anthony ^a   Hill, Suzanne R ^b   Henry, David A ^b  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; ECONOMIC ASPECT; HEALTH CARE COST; HUMAN; LETTER; MEDICAL DECISION MAKING; MEDICAL LITERATURE; MEDICAL RESEARCH; MEDICAL SOCIETY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RESOURCE ALLOCATION;

EID: 33745228472     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.295.23.2723-b     Document Type: Letter

References (4)

1. Weinstein MC, Zeckhauser RJ. Critical ratios and efficient allocation. J Public Econ. 1973;2:147-157.
2. Lopert R, Lang D, Hill SR, Henry D. Differential pricing of drugs: a role for cost-effectiveness analysis? Lancet. 2002;359:2105-2107.
3. Gafni A, Birch S. Incremental cost-effectiveness ratios (ICERs): the silence of the lambda [published online ahead of print December 1, 2005]. Soc Sci Med. 2006;62:2091-2100.
4. George B, Harris A, Mitchell A. Cost-effectiveness analysis and the consistency of decision making: evidence from pharmaceutical reimbursement in Australia (1991-1996). Pharmacoeconomics. 2001;19:1103-1109.